Rospotrebnadzor announced the details of the research of the vaccine "Vector"

This is reported by Interfax with reference to the press service of Rospotrebnadzor. 

It is noted that with the start of mass production, the vaccine will be delivered to medical institutions that provide vaccination of citizens. 

“After registration of the vaccine, centers for post-registration research will be determined, in which 30,000 volunteers will take part,” the department said.

Earlier it was reported that post-registration tests of the vaccine "Vector" will start in November-December.